Objectives: ESBL/AmpC-producing Enterobacteriaceae are an emerging public health concern. As households with preschool children may substantially contribute to the community burden of antimicrobial resistance, we determined the prevalence, risk factors and co-carriage of ESBL/AmpC-producing bacteria in preschool children and their parents.
Introduction
The global spread of AmpC and ESBL-producing Enterobacteriaceae conferring resistance to extended-spectrum cephalosporins represents an emerging public health threat. 1 Bacteria harbouring ESBLs may cause both community-onset bacteraemia and healthcare-associated infections. 2 Moreover, infections caused by such bacteria have been associated with increased morbidity and mortality, 3 most likely because of delays in administering appropriate therapy. 4 In the Netherlands, infections caused by ESBL-producing bacteria seem to increase in hospitalized patients, in residents of long-term care facilities (LTCFs) and in those consulting their general practitioner (GP) (www.ISIS-web.nl). 5 ESBL/AmpC-producing bacteria can be detected in patients in healthcare settings and among healthy subjects in the community. 6 -9 Yet, risk factors for carriage have mainly been investigated in adult hospitalized patients. 10 -14 Frequently reported risk factors for carriage of ESBL/AmpC-producing bacteria are prior antibiotic use, hospitalization, 15, 16 prior ESBL carriage, nursing home residency, 15 exposure to farm and companion animals, 17 and foreign travel. 8,9,17 -19 Empirical data on carriage of ESBL/AmpC-producing bacteria (ESBL/AmpC carriage) in healthy children are scarce. In a recent Dutch study 20 the reported overall ESBL/AmpC carriage prevalence was 4.5% among children attending daycare centres (DCCs), being as high as 8.0% among those ≤1 year old, and with risk factors being mainly related to the hygiene practices enforced in the DCC. ESBL/AmpC prevalence in non-DCC-attending children of preschool age and the occurrence of co-carriage of ESBL/AmpC-producing bacteria in children and their parents were not determined. In a single study the prevalence of carriage of ESBL-producing bacteria was 96% among adoptees from Mali on arrival in France and within-family transmission was observed in 23% of the families. 21 As transmission of ESBL/AmpC resistance in households with preschool children may substantially contribute to the community burden of antimicrobial resistance, we aimed to quantify the prevalence of carriage and of co-carriage of ESBL/AmpC-producing bacteria in preschool children and their parents and risk factors for carriage to better inform public health policy makers.
Methods

Study design and epidemiological data collection
We performed each month from April 2013 to January 2015 a crosssectional survey of ESBL/AmpC-producing bacteria in the stool of preschool children (≤4 year-old) and their parents, in the Netherlands. During the 2 years of study, 2000 children per month, 1 per family, were randomly selected (without replacement) from Dutch population registries of 335 (out of 415) municipalities, covering 78% of the general population of the Netherlands ( 16.9 million inhabitants). The parents of the selected children were invited by regular mail to complete a web-based questionnaire addressing household characteristics, DCC attendance, chronic disease, medication use, clinical symptoms, medical care, occupation, animal contact, leisure activities and eating habits. The questionnaire was developed based on previous population-based studies conducted in the Netherlands 22 -25 and referred to the addressed child and to one parent chosen freely within the household; questions referred to the prior 4 weeks. The degree of urbanization (,500, 500-2500, .2500 addresses/km 2 ) and the socio-economic status [SES; a normalized score ranging from 26.8 (low SES area) to 3.1 (high SES area), based on income, employment and education] were obtained at the postcode level from Statistics Netherlands (http ://www.cbs.nl/en-GB/menu/home/default.htm). A detailed explanation of the study design can be found in a previous paper. 26 
Faecal sample collection
Upon completion of the questionnaire, parents were asked to provide a faecal sample from the sampled child and from the participating parent, regardless of the answers given in the questionnaire. If willing to submit the samples, we provided a stool sample collection kit containing two pre-labelled sterile tubes in order to collect the samples from the child and the parent. In addition, information was given on how to collect and send back the samples to the laboratory using a pre-stamped envelope. An additional questionnaire was also completed by the participants to check whether new symptoms had occurred in the 2 weeks prior to stool sampling.
Ethics
This study received ethics approval from the Medical Research Ethics Committee of Utrecht University (WAG/om/13/048247). Informed consent was obtained from all subjects.
ESBL/AmpC gene detection
All stool samples were enriched in 3 mL of LB broth supplemented with 1 mg/L cefotaxime. MacConkey agar plates with 1 mg/L cefotaxime were used as a selective medium for extended-spectrum cephalosporin-resistant (ESCR) isolates. In case of growth, up to five colonies based on different morphologies were picked from agar plates, and speciated using a MALDI-TOF MS method. Escherichia coli, Enterobacter cloacae and Klebsiella pneumoniae isolates were screened for ESBL/AmpC genes by micro-array analysis (Check-MDR CT-101, Check-points, the Netherlands), PCR and subsequent sequencing as described previously. 27 
Semi-quantitative culture
The number of cfu/g of faeces present in an E. coli-positive stool sample was determined semi-quantitatively with the 'running-drop method'. Tenfold dilutions were made from faecal suspension of which 10 mL per suspension was allowed to run down the surface of Tryptone Bile X-glucuronide agar (TBX) plates and incubated overnight at a temperature of 378C. Consequently, the cfu were based on the highest dilution where growth was still visible. In order to determine the ratio of ESBL/AmpC-positive and -susceptible bacteria, two plates were used, one with 1 mg/L cefotaxime and one without cefotaxime. The detection limit was 10 2 cfu/g of stool.
Data analysis
Logistic regression analysis was performed to identify factors associated with ESBL/AmpC carriage in children and their parents. A total of 29 and 41 putative risk factors for ESBL/AmpC carriage in children and parents (Table 1) were assessed univariately. Based on the number of observations, robustness to reporting/prevarication bias and biological plausibility with regard to ESBL/AmpC carriage, variables with a P value ≤0.20 in univariate analysis were selected for inclusion in a multivariable model using a manual backward stepwise approach in which variables having a P, 0.05 remained in the model. Potential confounding effects were addressed by retaining variables whose exclusion from the models changed the effect of the other covariates by ≥10%. Interactions between independent variables were also tested and the final multivariable models were expanded to include the significant (P, 0.05) interaction terms, if any. Collinearities between independent variables were checked prior to multivariable analysis and selection between collinear variables was made based on an improved model fit as revealed by the Akaike information criterion (AIC). In addition, sensitivity analysis was performed by including only ESBL-producing bacteria as outcome variable in the models (i.e. AmpC-producing bacteria were excluded). Associations were expressed as ORs and corresponding 95% CIs. Co-carriage of ESBL/AmpC-producing bacteria in child -parent pairs was assessed independently of risk factors for ESBL/AmpC carriage in children and parents. Subsequently, to determine whether the number (cfu) of ESBL/AmpC-producing bacteria in children influenced the risk of the respective parent being a carrier, a logistic regression model was built in which the cfu in the children was included as predictor of ESBL/ AmpC carriage in the parents (outcome variable).
Because of the limited number of outcome events, to cross-validate the models, bootstrapped ORs and bias-corrected bootstrap 95% CIs were also calculated (1000 replications) and presented with the standard ones as suggested elsewhere. 28 The bootstrap procedure consisted of drawing 1000 random samples with replacement from the observed data and using these samples to feed back into the models. All multivariable models showed an overall statistical significance (likelihood-ratio x 2 -test, P,0.05) and goodness-of-fit (Hosmer-Lemeshow test, P. 0.05). Statistical analysis was performed using STATA 13.
We also calculated the expected probability (P) of randomly finding the same ESBL/AmpC genotype (GT) x in a child-parent pair as performed previously, 29 with P being given by:
where S x is the summation over all GTs found in both children and parents and M is the overall prevalence of ESBL/AmpC carriage.
Results
In total, 49732 households were invited and 10109 (20.3%) completed the questionnaire, of which 3376 (33.4%) were willing to and of which 1016 did provide a faecal sample. We received and tested for ESBL/AmpC-producing bacteria a total of 1999 samples (1004 from children and 995 from parents General baseline characteristics are presented in Table S1 (available as Supplementary data at JAC Online).
Prevalence
Overall, 80 (4.0%, 95% CI 3.2% -5.0%) samples were ESBL/AmpC positive: 35 (3.5% 95% CI 2.5% -4.8%) from children (5 were only AmpC-producing bacteria) and 45 (4.5% 95% CI 3.4% -6.0%) from parents (3 were only AmpC-producing bacteria). Adjusted prevalence estimates stratified by SES, urbanization degree, DCC attendance, age and nationality are presented in Table 1 . From April 2013 to December 2013, the prevalence in children was 3.3% (95% CI 2.0% -5.4%) and 5.2% (95% CI 3.5% -7.6%) in parents. From January 2014 to January 2015, the prevalence in children was 3.6% (95% CI 2.2% -5.8%) and 3.9% (95% CI 2.4% -6.1%) in parents.
In children, E. coli was the predominant species (n ¼ 32; 91.4%), followed by E. cloacae (n ¼ 2; 5.7%) and K. pneumoniae (n ¼ 1; 2.9%). In parents, E. coli was also the most prevalent (n¼ 43; 95.6%) followed by K. pneumoniae (n¼2; 4.4%).
The most prevalent genotypes found in children were bla CTX-M-15 (n ¼ 10; 27.8%), bla SHV-12 (n ¼ 5; 13.9%), bla CMY-2 (n ¼ 4; 11.1%) and bla CTX-M-14 (n ¼ 4; 11.1%), and in parents were bla CTX-M-15 (n ¼ 16; 34.0%), bla CTX-M-1 (n ¼ 8; 17.0%) and bla CTX-M-14 (n ¼ 6; 12.8%) (Figure 1 and Table S2 ). In children attending DCCs the most prevalent genotypes were bla CTX-M-15 (n ¼ 6; 25.0%) and bla SHV-12 (n ¼ 5; 20.8%) and in ESBLs/AmpCs in young children and their parents JAC children not-attending DCCs bla CTX-M-15 (n ¼ 3; 27.3%), bla CMY-2 (n ¼ 2; 18.2%) and bla CTX-M-14 (n ¼ 2; 18.2%) ( Table 2) .
Risk factors
Having a child carrying ESBL/AmpC-producing bacteria was a risk factor for ESBL/AmpC carriage in the parents (OR 19.7, 95% CI 9.2 -42.4). In addition, having a parent carrying ESBL/AmpCproducing bacteria was a risk factor for children as well and the same effect estimates were observed.
In the final multivariable model for ESBL/AmpC carriage in children, attending a DCC (OR 2.1 95% CI 1.0 -4.3) was the only other significant risk factor retained, independent from the risk factor of having an ESBL/AmpC-positive parent (Table 3) .
In the final multivariable model for ESBL/AmpC carriage in parents (Table 4) , the only significant risk factor was having one or more children attending a DCC (OR 2.2 95% CI 1.1 -4.2). Bootstrap analysis confirmed the significance of this association (Table 4) . In both models for children and parents, neither confounders nor interactions show any significant effect and were therefore excluded from the models. Logistic regression models of children and parents with only ESBL-and not AmpC-producing bacteria yielded the same risk factors, even after bootstrapping (data not shown).
Co-carriage
There was a trend towards an association between the semiquantitative ESBL/AmpC count in the children's faecal samples and the risk of co-carriage in the parents. Compared with the absence of detectable ESBL/AmpC-producing bacteria, an ESBL/ AmpC cfu count of .0 to ≤10 2 /g in children was associated with an OR of 12.7 (95% CI 3.1-51.4), and a cfu count of ≥10 3 /g was associated with an OR of 23.2 (95% CI 9.8-55.3) for ESBL/AmpC carriage in parents. Genotypes bla CTX-M-14 , bla CTX-M-27 , bla CTX-M-3 , bla CTX-M-14b and bla TEM-52c co-occurred in the child -parent pairs significantly more often than expected by chance (Table 5 ).
Discussion
In this study, the prevalence of ESBL/AmpC carriage in households was 4.0%, with comparable carriage prevalence among children and parents and with co-occurrence of resistance genotypes between children and parents. Attendance at DCCs was a risk factor for carriage for both children and parents.
The observed prevalence of 4.0% was lower than previous findings in the Dutch community. 6 -9,20,30 Yet direct comparison of these studies is hampered by differences in study design, populations under study and analytical methods used. Most studies were conducted in adult populations, and healthy children attending DCCs were studied only in one study. 20 In that study, children ≤1 year old had a higher prevalence (8.0%) compared with the older age groups (4.5%). The prevalence of carriage of ESBL/ AmpC-producing bacteria was 3.1% in the ≤1 year olds in the current study, and in children attending a DCC the ESBL/AmpC prevalence was lower (2.8%) as compared with the older age groups (3.6%). In a similar study conducted in France the reported prevalence of carriage with ESBL-producing bacteria was 6.4% in children attending DCCs. 31 In another French study, performed between 2010 and 2015, the observed overall ESBL prevalence was 7.6% (95% CI: 6.5% -9.0%) in children ,24 months old seeking paediatric attention, which is somewhat higher than the prevalence observed here. 32 In 2010, a Swedish study found a prevalence of 2.9% (95% CI: 1.4% -5.6%) in preschool children from the city of Uppsala, which is comparable to our findings. 33 bla CTX-M-15 was the most prevalent genotype in both children and parents, followed by bla CMY-2 and bla CTX-M-1 . The dominance of bla CTX-M-15 in the Netherlands is in line with the global human epidemiology of ESBL-producing bacteria. 34 The current study confirms the relevance of bla CMY-2 in children, accounting for 11.1% of all ESBL/AmpC-producing bacteria. Koningstein et al. 20 reported previously that in children attending DCCs in the Netherlands bla CMY-2 was the most prevalent genotype, accounting for 26% of all resistant isolates. The comparable distribution of genotypes in children and parents reflects the high rate of co-occurrence of genotypes in both groups. 
Calculated at the isolate level. van den Bunt et al.
DCC attendance was the only significant risk factor for carriage of ESBL/AmpC-producing bacteria in both children and parents, and the absolute difference between children attending (4.6%) and not attending DCC (2.2%) was 2.4%. Moreover, there was a trend towards an association between the semi-quantitative level of ESBL/AmpC carriage in children and the likelihood of carriage in parents, and co-carriage of specific genotypes in child -parent pairs occurred more frequently than expected based on chance alone.
To the best of our knowledge these associations have not been reported before. The higher prevalence may result from the intensity of contacts among children in DCC, also resulting in higher carriage rates of enteropathogens 35 and increased risks for gastrointestinal and respiratory infections. 26,36 -38 DCCs, therefore, may play a role in the spread of ESBL/AmpC-producing bacteria among children, and also facilitate further spread within households. This is also supported by other studies in similar study populations where parents of children with influenza-like-illness, 38 gastroenteritis 26 and in the presence of enteropathogens (bacteria, viruses and parasites) 39 were at increased risk of experiencing the same symptoms as their children during the same 4 week period. The possibility of transmission of ESBL-producing bacteria within families was previously demonstrated in families that adopted a child, 21 after community-acquired infections 40, 41 and after hospital-acquired carriage of ESBL-producing bacteria. 42 In another study infants became colonized with bla CTX-M-15 -producing K. pneumoniae during a neonatal ICU outbreak and the same bacteria were subsequently detected in 32% of the households. 43 An alternative explanation for the observed associations would be differences in exposure to external sources, such as contaminated foods or environment. More studies are needed to disentangle the relevance of these different acquisition routes in the epidemiology of ESBL/ AmpC-producing bacteria.
Few other risk factors for carriage of ESBL/AmpC-producing bacteria in healthy children have been described. A recent French study investigated ESBL occurrence and risk factors in children ,24 months of age visiting 18 paediatricians who participated in the study and observed that those children cared for at ORs and bias-corrected bootstrap 95% CIs based upon 1000 replications. ESBLs/AmpCs in young children and their parents JAC home were at increased risk for carriage of ESBL-producing bacteria. 32 This is different from our finding where DCC attendance is a risk factor for carriage of ESBL/AmpC-producing bacteria. Several explanations are possible and may be related to the different populations under investigation (i.e. 'healthy' children selected at random from the general population in the present study versus paediatrician-attending children in the French study), the different age groups considered (i.e. 6-24 months in the French study versus 0 -48 months in the present one), and different (hitherto unknown) factors associated with home-based childcare in France versus the Netherlands, e.g. socio-economic status, ethnic background, etc. Another study, conducted in Lebanese children, observed that regular consumption of all types of meat (including chicken) was a risk factor for ESBL/AmpC carriage. 44 In the current study, we determined associations between food consumption practices and ESBL/AmpC carriage in parents only, but significant associations were not detected.
This study has some limitations. The relatively low number of carriers of ESBL/AmpC-producing bacteria limited statistical power to investigating some relatively less prevalent exposures in our (predominantly healthy) population, such as hospitalization or antibiotic use. In addition, due to the study design, we could not investigate some established risk factors, e.g. travelling abroad. Moreover, although potential confounding effects were addressed, the possibility of residual confounding is always there. Furthermore, the 20.3% response rate may have caused bias. For instance, subjects experiencing (gastrointestinal) complaints may have been more motivated to submit a faecal sample. However, the response rate was comparable to other studies on ESBL epidemiology in the Netherlands. 7, 9 Recall bias may also have occurred, but it is unlikely that this led to differential misclassification, as there is no reason to assume different recall between carriers and non-carriers.
In conclusion, carriage of ESBL/AmpC-producing bacteria was detected in 4% of households with preschool children, with DCC attendance being the most important risk factor for carriage in both children and parents. The high co-carriage of resistance genes between children and their parents, the semi-quantitative carriage load in children and the risk of carriage among parents suggest the occurrence of household transmission.
